MediWound Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDWD research report →
About the company
MediWound Ltd. , a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
- CEO
- Ofer Gonen
- IPO
- 2014
- Employees
- 121
- HQ
- Yavne, IL
Price Chart
- Market Cap
- $164.68M
- P/E
- -6.71
- P/S
- 11.37
- P/B
- 4.71
- EV/EBITDA
- -8.64
- Div Yield
- 0.00%
- Gross Margin
- 19.61%
- Op Margin
- -193.62%
- Net Margin
- -180.30%
- ROE
- -67.22%
- ROIC
- -47.30%
- Revenue
- $16.96M · -16.14%
- Net Income
- $-23,879,000 · 20.99%
- EPS
- $-2.10 · 30.69%
- Op Income
- $-25,279,000
- FCF YoY
- -0.69%
- 52W High
- $21.25
- 52W Low
- $13.54
- 50D MA
- $15.47
- 200D MA
- $17.19
- Beta
- 0.15
- Avg Volume
- 90.86K
Get TickerSpark's AI analysis on MDWD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | SHAMIR NACHUM | buy | 5,825 |
| Jun 3, 26 | SHAMIR NACHUM | buy | 175 |
| Jun 1, 26 | Fox David Morton | buy | 1,797 |
| Jun 1, 26 | Fox David Morton | buy | 10 |
| Jun 1, 26 | Fox David Morton | buy | 1,730 |
| May 29, 26 | Rubinstein Samuel | buy | 150 |
| Mar 18, 26 | Driver Vickie Rae | other | 0 |
| Mar 18, 26 | Driver Vickie Rae | other | 0 |
| Jun 29, 21 | Driver Vickie Rae | other | 14,285 |
| Jun 15, 22 | Driver Vickie Rae | other | 1,607 |
Our MDWD coverage
Recent articles, reports, and earnings notes.
No research on MDWD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDWD report →Similar companies
Peers in the same neighborhood.